Transforming growth factor β1 contributes to the invasiveness of pancreatic ductal adenocarcinoma cells through the regulation of CD24 expression

Yoshiki Kitaura, Nobuhito Chikazawa, Takehiko Tasaka, kenji nakano, Masao Tanaka, Hideya Ohnishi, Mitsuo Katano

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objectives: The aim of this study was to investigate the role of CD24 in the invasiveness of pancreatic ductal adenocarcinoma (PDAC). Methods: We used 2 human PDAC cell lines containing large numbers of CD24-positive (CD24 +) cells (>65%; AsPC-1 cells) or few CD24 + cells (<20%; CFPAC-1 cells). Invasiveness was estimated using the Matrigel invasion assay. The role of CD24 in invasiveness was evaluated using small interference RNA against CD24 mRNA. Results: The invasive ability of CD24 + cells collected by cell sorter was higher than that of CD24-negative (CD24 -) cells. On the other hand, silencing of CD24 decreased the invasive ability of CD24 + cells. Importantly, considerable amount of CD24 + cells was converted to CD24 - cells within 24 hours under in vitro culture condition. Transforming growth factor β1 significantly inhibited this conversion and consequently maintained the high invasiveness of CD24 + cells. Conclusions: Our data show that CD24 contributes to the invasive ability of PDAC and also suggest that transforming growth factor β1 may contribute to the invasiveness of PDAC by suppressing the conversion from CD24 + cells to CD24 - cells at the tumor site.

Original languageEnglish
Pages (from-to)1034-1042
Number of pages9
JournalPancreas
Volume40
Issue number7
DOIs
Publication statusPublished - Oct 1 2011

Fingerprint

Transforming Growth Factors
Adenocarcinoma
RNA Interference

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Internal Medicine
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Transforming growth factor β1 contributes to the invasiveness of pancreatic ductal adenocarcinoma cells through the regulation of CD24 expression. / Kitaura, Yoshiki; Chikazawa, Nobuhito; Tasaka, Takehiko; nakano, kenji; Tanaka, Masao; Ohnishi, Hideya; Katano, Mitsuo.

In: Pancreas, Vol. 40, No. 7, 01.10.2011, p. 1034-1042.

Research output: Contribution to journalArticle

Kitaura, Yoshiki ; Chikazawa, Nobuhito ; Tasaka, Takehiko ; nakano, kenji ; Tanaka, Masao ; Ohnishi, Hideya ; Katano, Mitsuo. / Transforming growth factor β1 contributes to the invasiveness of pancreatic ductal adenocarcinoma cells through the regulation of CD24 expression. In: Pancreas. 2011 ; Vol. 40, No. 7. pp. 1034-1042.
@article{e29efe2dd75648f8b14c7ba84659812d,
title = "Transforming growth factor β1 contributes to the invasiveness of pancreatic ductal adenocarcinoma cells through the regulation of CD24 expression",
abstract = "Objectives: The aim of this study was to investigate the role of CD24 in the invasiveness of pancreatic ductal adenocarcinoma (PDAC). Methods: We used 2 human PDAC cell lines containing large numbers of CD24-positive (CD24 +) cells (>65{\%}; AsPC-1 cells) or few CD24 + cells (<20{\%}; CFPAC-1 cells). Invasiveness was estimated using the Matrigel invasion assay. The role of CD24 in invasiveness was evaluated using small interference RNA against CD24 mRNA. Results: The invasive ability of CD24 + cells collected by cell sorter was higher than that of CD24-negative (CD24 -) cells. On the other hand, silencing of CD24 decreased the invasive ability of CD24 + cells. Importantly, considerable amount of CD24 + cells was converted to CD24 - cells within 24 hours under in vitro culture condition. Transforming growth factor β1 significantly inhibited this conversion and consequently maintained the high invasiveness of CD24 + cells. Conclusions: Our data show that CD24 contributes to the invasive ability of PDAC and also suggest that transforming growth factor β1 may contribute to the invasiveness of PDAC by suppressing the conversion from CD24 + cells to CD24 - cells at the tumor site.",
author = "Yoshiki Kitaura and Nobuhito Chikazawa and Takehiko Tasaka and kenji nakano and Masao Tanaka and Hideya Ohnishi and Mitsuo Katano",
year = "2011",
month = "10",
day = "1",
doi = "10.1097/MPA.0b013e31821ea286",
language = "English",
volume = "40",
pages = "1034--1042",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Transforming growth factor β1 contributes to the invasiveness of pancreatic ductal adenocarcinoma cells through the regulation of CD24 expression

AU - Kitaura, Yoshiki

AU - Chikazawa, Nobuhito

AU - Tasaka, Takehiko

AU - nakano, kenji

AU - Tanaka, Masao

AU - Ohnishi, Hideya

AU - Katano, Mitsuo

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Objectives: The aim of this study was to investigate the role of CD24 in the invasiveness of pancreatic ductal adenocarcinoma (PDAC). Methods: We used 2 human PDAC cell lines containing large numbers of CD24-positive (CD24 +) cells (>65%; AsPC-1 cells) or few CD24 + cells (<20%; CFPAC-1 cells). Invasiveness was estimated using the Matrigel invasion assay. The role of CD24 in invasiveness was evaluated using small interference RNA against CD24 mRNA. Results: The invasive ability of CD24 + cells collected by cell sorter was higher than that of CD24-negative (CD24 -) cells. On the other hand, silencing of CD24 decreased the invasive ability of CD24 + cells. Importantly, considerable amount of CD24 + cells was converted to CD24 - cells within 24 hours under in vitro culture condition. Transforming growth factor β1 significantly inhibited this conversion and consequently maintained the high invasiveness of CD24 + cells. Conclusions: Our data show that CD24 contributes to the invasive ability of PDAC and also suggest that transforming growth factor β1 may contribute to the invasiveness of PDAC by suppressing the conversion from CD24 + cells to CD24 - cells at the tumor site.

AB - Objectives: The aim of this study was to investigate the role of CD24 in the invasiveness of pancreatic ductal adenocarcinoma (PDAC). Methods: We used 2 human PDAC cell lines containing large numbers of CD24-positive (CD24 +) cells (>65%; AsPC-1 cells) or few CD24 + cells (<20%; CFPAC-1 cells). Invasiveness was estimated using the Matrigel invasion assay. The role of CD24 in invasiveness was evaluated using small interference RNA against CD24 mRNA. Results: The invasive ability of CD24 + cells collected by cell sorter was higher than that of CD24-negative (CD24 -) cells. On the other hand, silencing of CD24 decreased the invasive ability of CD24 + cells. Importantly, considerable amount of CD24 + cells was converted to CD24 - cells within 24 hours under in vitro culture condition. Transforming growth factor β1 significantly inhibited this conversion and consequently maintained the high invasiveness of CD24 + cells. Conclusions: Our data show that CD24 contributes to the invasive ability of PDAC and also suggest that transforming growth factor β1 may contribute to the invasiveness of PDAC by suppressing the conversion from CD24 + cells to CD24 - cells at the tumor site.

UR - http://www.scopus.com/inward/record.url?scp=80052962216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052962216&partnerID=8YFLogxK

U2 - 10.1097/MPA.0b013e31821ea286

DO - 10.1097/MPA.0b013e31821ea286

M3 - Article

C2 - 21697762

AN - SCOPUS:80052962216

VL - 40

SP - 1034

EP - 1042

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 7

ER -